Journal of Neurology

, Volume 246, Supplement 1, pp I1–I185 | Cite as

Ninth Meeting of the European Neurological Society 5–9 June, 1999, Milan, Italy

Abstracts of Symposia, Free Communications and Posters
Abstracts

References

  1. 1.
    Woo KS, White HD. Comparative tolerability profiles of thrombolytic agents.Drug Safety 1993; 8: 19–29.PubMedCrossRefGoogle Scholar
  2. 2.
    Del Zoppo GJ, Zeumer H, Harker LA. Thrombolytic therapy in stroke: possibilities and hazards. Stroke 1986; 17:595–607.PubMedGoogle Scholar
  3. 3.
    Haley EC Jr. Thrombolytic therapy for acute ischemic stroke. Clin Neuropharmacol 1993; 16: 179–94.PubMedCrossRefGoogle Scholar
  4. 4.
    Von Kummer R, Meyding-Lamade U, Forsting M, et al. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. Am J Neuroradiol 1994; 15:9–15.Google Scholar
  5. 5.
    Hacke W, Zeumer H, Ferbert A, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988; 19: 1216–22.PubMedGoogle Scholar
  6. 6.
    Del Zoppo GJ, Pessin MS, Mori E, et al. Thrombolytic intervention in acute thrombotic and embolic stroke. Sem Neurol 1991; 11 (4):368–84.CrossRefGoogle Scholar
  7. 7.
    Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274: 1017–25.PubMedCrossRefGoogle Scholar
  8. 8.
    Hacke W. Thrombolytic therapy in acute ischemic stroke — an update. Fibrinolysis 1994;8 (Suppl 1): 216–20.CrossRefGoogle Scholar
  9. 9.
    Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992;42:976–82.PubMedGoogle Scholar
  10. 10.
    Yamaguchi T, Hayakawa T, Kikichi H, et al. Intravenous rt-PA in acute embolic stroke. In: Hacke W, Del Zoppo GJ, Hirschberg M, eds. Thrombolytic therapy in acute ischemic stroke. Berlin: Springer Verlag 1991;168–74.Google Scholar
  11. 11.
    The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–7.CrossRefGoogle Scholar
  12. 12.
    The multicenter Acute Stroke Trial Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med 1996; 335:145–50.CrossRefGoogle Scholar
  13. 13.
    Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Randomized controlled trial of streptokinase, aspirin and combination of both in acute ischemic stroke. Lancet 1995; 346: 1509–1514.Google Scholar
  14. 14.
    Donnan GA, Davis SM, Chambers, et al. Trials of streptokinase in acute ischemic stroke. Lancet 1995; 345:578–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Hacke W, Kaste M, Fieschi C et al for the second European-Australasian Acute Stroke Study Investigators (1998) Randomised double blind trial of thrombolytic therapy with intravenous alteplase in acue ischaemic stroke (ECASS II) Lancet 352: 1245–1251PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1999

Personalised recommendations